ArticleNature communications2016

Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia.

Francis P Pankowicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.